bioMérieux ConnectionAn educational resource brought to you by bioMérieux, Inc.
An educational resource brought to you by bioMérieux, Inc.
Since 2017, the FDA has quickly adjusted processes, expanded capabilities, and created new guidelines specifically for ATMPs to keep up with the pace of the industry and discover and penalize developers who do not abide by regulations.
Use these three key takeaways to better communicate the importance of innovation in your organization. With scientific storytelling, data helps you make a difference.
The ATMP landscape has been growing at a rapid rate since 2017, a momentous year in which three cell and gene therapies were approved—all the first of their kind.
Parkinson’s Disease. Diabetes. Muscular dystrophy. These diseases all lack cures, but they also share another important similarity: the quest for their cures is playing out in the field of ATMPs.
At this year’s World Anti-Microbial Resistance Congress, Dr. Tristan Timbrook delivered a...
WASH, which stands for water, sanitation, and hygiene, are basic...